Public-registry site landscape for NCT07740564, a Dry Eye study sponsored by Ocumension Therapeutics (Suzhou) Co., Ltd. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07740564 (registry record) |
| Sponsor | Ocumension Therapeutics (Suzhou) Co., Ltd |
| Condition(s) | Dry Eye |
| Phase | PHASE3 |
| Listed sites | 49 |
| Site countries | China |
Eichor generates a preliminary site-risk snapshot for NCT07740564 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →